Patents by Inventor Linying Su

Linying Su has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NUCLEIC ACID INTERFERENCE PHARMACEUTICAL COMPOSITION, AND DRUG FOR TREATING COLORECTAL CANCER, GASTRIC CANCER, AND PROSTATE CANCER
    Publication number: 20250011788
    Abstract: Provided herein are nucleic acid interference pharmaceutical compositions, and drugs for treating colorectal cancer, gastric cancer and prostate cancer. For two targets (TGF-?1 and MyD88) related to tumor microenvironment and tumor metastasis in colorectal cancer, gastric cancer, and prostate cancer, an MyD88/TGF-?1 dual-target nucleic acid interference pharmaceutical composition (composition number STP500) is designed and selected, which includes an active ingredient and a pharmaceutically acceptable carrier. The active ingredient includes a first active ingredient capable of inhibiting and silencing the expression of the MyD88 gene and a second active ingredient capable of inhibiting and silencing the expression of TGF-?1 gene.
    Type: Application
    Filed: March 16, 2023
    Publication date: January 9, 2025
    Applicant: SIRNAOMICS BIOPHARMACEUTICALS (SUZHOU) CO., LTD.
    Inventors: Deling Wang, Linying Su, Zhiyuan Wang, Jin Zhang, Xilong Liu, Cheng Zhou, Jun Xu, Patrick Y Lu